Literature DB >> 25483536

Ten years (2004-2014) of influenza surveillance in Northern Italy.

Elena Pariani1, Antonella Amendola, Alessandra Piatti, Giovanni Anselmi, Alberto Ranghiero, Laura Bubba, Anna Maria Rosa, Laura Pellegrinelli, Sandro Binda, Liliana Coppola, Maria Gramegna, Alessandro Zanetti.   

Abstract

As the regional influenza reference centre operating within the Italian network InfluNet, here we report data on virological and epidemiological surveillance of influenza, as well as on the vaccination coverage rates achieved in Lombardy (Northern Italy) over 10 consecutive winter seasons (2004-2014).   Over the past 10 years, influenza vaccine coverage declined both in the general population (from 15.7% in 2004-2005 to 11.7% in 2013-2014) and in the vaccine-target population of individuals ≥65-y-of-age (from 65.3% in 2004-2005 to 48.6% in 2013-2014) and is far below the minimum planned threshold level (75%). The highest influenza-like illness (ILI) rates were recorded during the 2004-2005 and 2009-2010 epidemics (peak incidence: 12.04‰ and 13.28‰, respectively). Both seasons were characterised by the introduction of novel viral strains: A/Fujian/411/2002(H3N2) (a drifted hemagglutinin variant) and A/California/7/2009(H1N1) pandemic virus (a swine origin quadruple reassortant), respectively. Because the antigenic match between vaccine and circulating strains was good in both of these seasons, a relevant proportion of cases may have been prevented by vaccination. A different situation was observed during the 2011-2012 season, when ILI morbidity rates in individuals ≥65-y-of-age were 1.5-6-fold higher than those registered during the other epidemics under review. The higher morbidity resulted from the circulation during the 2011-2012 season of an A/Victoria/361/2011(H3N2)-like variant that presented a reduced genetic match with the A(H3N2) strain included in the 2011-2012 vaccine composition. The continuous surveillance of the characteristics of circulating viruses is an essential tool for monitoring their matching with seasonal vaccine strains. Strategies to increase coverage rates are warranted.

Entities:  

Keywords:  Influenza virus; epidemiology; influenza surveillance network; influenza vaccination; phylogeny; vaccine coverage

Mesh:

Substances:

Year:  2014        PMID: 25483536      PMCID: PMC4514189          DOI: 10.4161/hv.35863

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  13 in total

Review 1.  The evolution of human influenza viruses.

Authors:  A J Hay; V Gregory; A R Douglas; Y P Lin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-12-29       Impact factor: 6.237

2.  Molecular characterization of influenza B viruses circulating in northern Italy during the 2001-2002 epidemic season.

Authors:  Filippo Ansaldi; Pierlanfranco D'Agaro; Daniela De Florentiis; Simona Puzelli; Yi Pu Lin; Victoria Gregory; Michael Bennett; Isabella Donatelli; Roberto Gasparini; Pietro Crovari; Alan Hay; Cesare Campello
Journal:  J Med Virol       Date:  2003-07       Impact factor: 2.327

3.  Genetic and antigenic variation in the haemagglutinin of recently circulating human influenza A (H3N2) viruses in the United Kingdom.

Authors:  J S Ellis; P Chakraverty; J P Clewley
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

4.  Multiple genotypes of influenza B viruses cocirculated in Taiwan in 2004 and 2005.

Authors:  Guang-Wu Chen; Shin-Ru Shih; Mei-Ren Hsiao; Shih-Cheng Chang; Shu-Hung Lin; Chien-Fen Sun; Kuo-Chien Tsao
Journal:  J Clin Microbiol       Date:  2007-02-28       Impact factor: 5.948

Review 5.  The 2009-2010 influenza pandemic: effects on pandemic and seasonal vaccine uptake and lessons learned for seasonal vaccination campaigns.

Authors:  Gregory A Poland
Journal:  Vaccine       Date:  2010-09-07       Impact factor: 3.641

Review 6.  The need for quadrivalent vaccine against seasonal influenza.

Authors:  Robert B Belshe
Journal:  Vaccine       Date:  2010-09-07       Impact factor: 3.641

7.  Changes in the hemagglutinins and neuraminidases of human influenza B viruses isolated in Italy during the 2001-02, 2002-03, and 2003-04 seasons.

Authors:  Simona Puzelli; Fabiola Frezza; Concetta Fabiani; Filippo Ansaldi; Laura Campitelli; Yi Pu Lin; Victoria Gregory; Michael Bennett; Pierlanfranco D'Agaro; Cesare Campello; Pietro Crovari; Alan Hay; Isabella Donatelli
Journal:  J Med Virol       Date:  2004-12       Impact factor: 2.327

8.  Genetic drift influenza A(H3N2) virus hemagglutinin (HA) variants originated during the last pandemic turn out to be predominant in the 2011-2012 season in Northern Italy.

Authors:  Elena Pariani; Antonella Amendola; Erika Ebranati; Alberto Ranghiero; Alessia Lai; Giovanni Anselmi; Gianguglielmo Zehender; Alessandro Zanetti
Journal:  Infect Genet Evol       Date:  2012-11-19       Impact factor: 3.342

9.  Influenza AH1N2 viruses, United Kingdom, 2001-02 influenza season.

Authors:  Joanna S Ellis; Adriana Alvarez-Aguero; Vicky Gregory; Yi Pu Lin; A Hay; Maria C Zambon
Journal:  Emerg Infect Dis       Date:  2003-03       Impact factor: 6.883

Review 10.  Influenza.

Authors:  Karl G Nicholson; John M Wood; Maria Zambon
Journal:  Lancet       Date:  2003-11-22       Impact factor: 79.321

View more
  16 in total

1.  Trends of influenza B during the 2010-2016 seasons in 2 regions of north and south Italy: The impact of the vaccine mismatch on influenza immunisation strategy.

Authors:  Andrea Orsi; Giuseppina Maria Elena Colomba; Fanny Pojero; Giuseppe Calamusa; Cristiano Alicino; Cecilia Trucchi; Paola Canepa; Filippo Ansaldi; Francesco Vitale; Fabio Tramuto
Journal:  Hum Vaccin Immunother       Date:  2017-08-03       Impact factor: 3.452

2.  [The universal influenza vaccination in children with Vaxigrip Tetra® in Italy: an evaluation of Health Technology Assessment].

Authors:  Sara Boccalini; Angela Bechini; Maddalena Innocenti; Gino Sartor; Federico Manzi; Paolo Bonanni; Donatella Panatto; Piero Luigi Lai; Francesca Zangrillo; Emanuela Rizzitelli; Mariasilvia Iovine; Daniela Amicizia; Chiara Bini; Andrea Marcellusi; Francesco Saverio Mennini; Alessandro Rinaldi; Francesca Trippi; Anna Maria Ferriero; Giovanni Checcucci Lisi
Journal:  J Prev Med Hyg       Date:  2018-05-30

3.  "PErCEIVE in Umbria": evaluation of anti-influenza vaccination's perception among Umbrian pharmacists.

Authors:  V Gianfredi; D Nucci; T Salvatori; F Orlacchio; M Villarini; M Moretti
Journal:  J Prev Med Hyg       Date:  2018-03-30

4.  Surveillance Data for Eight Consecutive Influenza Seasons in Sicily, Italy.

Authors:  Fabio Tramuto; Vincenzo Restivo; Claudio Costantino; Giuseppina Maria Elena Colomba; Carmelo Massimo Maida; Alessandra Casuccio; Francesco Vitale
Journal:  Am J Trop Med Hyg       Date:  2019-12       Impact factor: 2.345

5.  [Health Technology Assessment (HTA) of the introduction of influenza vaccination for Italian children with Fluenz Tetra®].

Authors:  Sara Boccalini; Elena Pariani; Giovanna Elisa Calabrò; Chiara DE Waure; Donatella Panatto; Daniela Amicizia; Piero Luigi Lai; Caterina Rizzo; Emanuele Amodio; Francesco Vitale; Alessandra Casuccio; Maria Luisa DI Pietro; Cristina Galli; Laura Bubba; Laura Pellegrinelli; Leonardo Villani; Floriana D'Ambrosio; Marta Caminiti; Elisa Lorenzini; Paola Fioretti; Rosanna Tindara Micale; Davide Frumento; Elisa Cantova; Flavio Parente; Giacomo Trento; Sara Sottile; Andrea Pugliese; Massimiliano Alberto Biamonte; Duccio Giorgetti; Marco Menicacci; Antonio D'Anna; Claudia Ammoscato; Emanuele LA Gatta; Angela Bechini; Paolo Bonanni
Journal:  J Prev Med Hyg       Date:  2021-09-10

6.  Longitudinal surveillance of influenza in Japan, 2006-2016.

Authors:  Shinako Inaida; Shigeo Matsuno; Jiro Okumura
Journal:  Sci Rep       Date:  2022-07-14       Impact factor: 4.996

7.  Why are older adults and individuals with underlying chronic diseases in Germany not vaccinated against flu? A population-based study.

Authors:  Birte Bödeker; Cornelius Remschmidt; Patrick Schmich; Ole Wichmann
Journal:  BMC Public Health       Date:  2015-07-07       Impact factor: 3.295

8.  Healthcare-seeking behaviour in case of influenza-like illness in the French general population and factors associated with a GP consultation: an observational prospective study.

Authors:  Matthieu Ariza; Caroline Guerrisi; Cécile Souty; Louise Rossignol; Clément Turbelin; Thomas Hanslik; Vittoria Colizza; Thierry Blanchon
Journal:  BJGP Open       Date:  2017-12-13

9.  Predominance of influenza B/Yamagata lineage viruses in Bulgaria during the 2017/2018 season.

Authors:  N S Korsun; S G Angelova; I T Trifonova; I L Georgieva; I S Tzotcheva; S D Mileva; S E Voleva; A M Kurchatova; P I Perenovska
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

Review 10.  The impact of influenza virus B in Italy: myth or reality?

Authors:  C Rizzo; A Bella
Journal:  J Prev Med Hyg       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.